BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4953556)

  • 1. [Research on the pathogenetic mechanisms of hemorrhages due to induced venous stasis. II. Role of fibrinolysis in the pathogenesis of the hemorrhagic phenomenon due to stasis].
    Neri Serneri GG; Rossi Ferrini PL; Franchi F; Paoletti P
    Haematologica; 1965; 50(4):251-66. PubMed ID: 4953556
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
    Ambrus JL; Schimert G; Lajos TZ; Ambrus CM; Mink IB; Lassman HB; Moore RH; Melzer J
    J Med; 1971; 2(2):65-81. PubMed ID: 4329735
    [No Abstract]   [Full Text] [Related]  

  • 3. [The development of fibrinolysis inhibitors].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):5-14. PubMed ID: 4173881
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolytic bleedings in urology].
    Lipsky H; Hubmer O
    Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on the pathogenetic mechanisms of hemorrhage due to induced venous stasis. V. Further contribution to the study of the behavior of some enzymatic activities of the blood after venous stasis in subjects with positive tourniquet tests. Considerations on the importance of the increase of permeability of the cell membrane and of lysosomes in the pathogenesis of the hemorrhagic phenomenon].
    Neri Serneri GG; Franchi F; Paoletti P; Rossi Ferrini PL; Ignesti C
    Haematologica; 1966; 51(12):1059-84. PubMed ID: 4967326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Syndromes of defibrination and fibrinolysis in acute leukemias].
    Kleinstein I; Dascălu M
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(3):619-24. PubMed ID: 5273295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological study of some inhibitors of fibrinolysis].
    Gavrilov AP
    Farmakol Toksikol; 1967; 30(4):460-3. PubMed ID: 5598902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA].
    Fischer M
    Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antifibrinolytic therapy].
    Levi M; ten Cate JW
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):613-7. PubMed ID: 7700404
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 16. [Localized fibrinolysis of the tonsil and antiplasmin compounds].
    Asaga M; Okamoto M; Asaga H; Kimura M
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):462-3. PubMed ID: 5106660
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of patients with the hemorrhagic form of erysipelas by using amben and parmidine].
    Cherkasov VL; Bol'shakova TD; Kuznetsov VA; Obrazberdyev S; Mikerin SM
    Vrach Delo; 1990 Apr; (4):113-5. PubMed ID: 2275146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro fibrinolysis of the buffer coat coagulum].
    Harms D; Schmalisch N
    Frankf Z Pathol; 1966; 75(2):148-57. PubMed ID: 5995081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic inhibitors].
    Nagamatsu A
    Saishin Igaku; 1966 Feb; 21(2):320-5. PubMed ID: 5966316
    [No Abstract]   [Full Text] [Related]  

  • 20. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.